TrialJournal of cardiovascular translational research2015

Short-Term Adjuvant Therapy with Terminalia arjuna Attenuates Ongoing Inflammation and Immune Imbalance in Patients with Stable Coronary Artery Disease: In Vitro and In Vivo Evidence.

Divya Kapoor et al.PubMed ↗Publisher ↗

No numbers read from the abstract.